127 related articles for article (PubMed ID: 29101232)
1. Isopeptide and ester bond ubiquitination both regulate degradation of the human dopamine receptor 4.
Peeler JC; Schedin-Weiss S; Soula M; Kazmi MA; Sakmar TP
J Biol Chem; 2017 Dec; 292(52):21623-21630. PubMed ID: 29101232
[TBL] [Abstract][Full Text] [Related]
2. Dopamine D4 receptor ubiquitination.
Skieterska K; Rondou P; Van Craenenbroeck K
Biochem Soc Trans; 2016 Apr; 44(2):601-5. PubMed ID: 27068976
[TBL] [Abstract][Full Text] [Related]
3. Lysine Residues Are Not Required for Proteasome-Mediated Proteolysis of the Auxin/Indole Acidic Acid Protein IAA1.
Gilkerson J; Kelley DR; Tam R; Estelle M; Callis J
Plant Physiol; 2015 Jun; 168(2):708-20. PubMed ID: 25888615
[TBL] [Abstract][Full Text] [Related]
4. Proteasomal degradation of ubiquitinated Insig proteins is determined by serine residues flanking ubiquitinated lysines.
Lee JN; Gong Y; Zhang X; Ye J
Proc Natl Acad Sci U S A; 2006 Mar; 103(13):4958-63. PubMed ID: 16549805
[TBL] [Abstract][Full Text] [Related]
5. KLHL12 Promotes Non-Lysine Ubiquitination of the Dopamine Receptors D4.2 and D4.4, but Not of the ADHD-Associated D4.7 Variant.
Skieterska K; Rondou P; Lintermans B; Van Craenenbroeck K
PLoS One; 2015; 10(12):e0145654. PubMed ID: 26717573
[TBL] [Abstract][Full Text] [Related]
6. Two Degradation Pathways of the p35 Cdk5 (Cyclin-dependent Kinase) Activation Subunit, Dependent and Independent of Ubiquitination.
Takasugi T; Minegishi S; Asada A; Saito T; Kawahara H; Hisanaga S
J Biol Chem; 2016 Feb; 291(9):4649-57. PubMed ID: 26631721
[TBL] [Abstract][Full Text] [Related]
7. Dopamine or biopterin deficiency potentiates phosphorylation at (40)Ser and ubiquitination of tyrosine hydroxylase to be degraded by the ubiquitin proteasome system.
Kawahata I; Ohtaku S; Tomioka Y; Ichinose H; Yamakuni T
Biochem Biophys Res Commun; 2015 Sep; 465(1):53-8. PubMed ID: 26225746
[TBL] [Abstract][Full Text] [Related]
8. Human liver cytochrome P450 3A4 ubiquitination: molecular recognition by UBC7-gp78 autocrine motility factor receptor and UbcH5a-CHIP-Hsc70-Hsp40 E2-E3 ubiquitin ligase complexes.
Wang Y; Kim SM; Trnka MJ; Liu Y; Burlingame AL; Correia MA
J Biol Chem; 2015 Feb; 290(6):3308-32. PubMed ID: 25451919
[TBL] [Abstract][Full Text] [Related]
9. A single mutation at lysine 241 alters expression and trafficking of the D2 dopamine receptor.
Kim OJ
J Recept Signal Transduct Res; 2008; 28(5):453-64. PubMed ID: 18946766
[TBL] [Abstract][Full Text] [Related]
10. Ubiquitin binding modulates IAP antagonist-stimulated proteasomal degradation of c-IAP1 and c-IAP2(1).
Blankenship JW; Varfolomeev E; Goncharov T; Fedorova AV; Kirkpatrick DS; Izrael-Tomasevic A; Phu L; Arnott D; Aghajan M; Zobel K; Bazan JF; Fairbrother WJ; Deshayes K; Vucic D
Biochem J; 2009 Jan; 417(1):149-60. PubMed ID: 18939944
[TBL] [Abstract][Full Text] [Related]
11. Ubiquitin-dependent and -independent proteasomal degradation of hepatitis B virus X protein.
Kim JH; Sohn SY; Benedict Yen TS; Ahn BY
Biochem Biophys Res Commun; 2008 Feb; 366(4):1036-42. PubMed ID: 18155658
[TBL] [Abstract][Full Text] [Related]
12. Characterization of the interaction between the dopamine D4 receptor, KLHL12 and β-arrestins.
Skieterska K; Shen A; Clarisse D; Rondou P; Borroto-Escuela DO; Lintermans B; Fuxe K; Xiang YK; Van Craenenbroeck K
Cell Signal; 2016 Aug; 28(8):1001-14. PubMed ID: 27155323
[TBL] [Abstract][Full Text] [Related]
13. KLHL12-mediated ubiquitination of the dopamine D4 receptor does not target the receptor for degradation.
Rondou P; Skieterska K; Packeu A; Lintermans B; Vanhoenacker P; Vauquelin G; Haegeman G; Van Craenenbroeck K
Cell Signal; 2010 Jun; 22(6):900-13. PubMed ID: 20100572
[TBL] [Abstract][Full Text] [Related]
14. Non-canonical ubiquitin-based signals for proteasomal degradation.
Kravtsova-Ivantsiv Y; Ciechanover A
J Cell Sci; 2012 Feb; 125(Pt 3):539-48. PubMed ID: 22389393
[TBL] [Abstract][Full Text] [Related]
15. Proteome-wide identification of ubiquitylation sites by conjugation of engineered lysine-less ubiquitin.
Oshikawa K; Matsumoto M; Oyamada K; Nakayama KI
J Proteome Res; 2012 Feb; 11(2):796-807. PubMed ID: 22053931
[TBL] [Abstract][Full Text] [Related]
16. Nitric oxide-regulated proteolysis of human CYP2B6 via the ubiquitin-proteasome system.
Lee CM; Tripathi S; Morgan ET
Free Radic Biol Med; 2017 Jul; 108():478-486. PubMed ID: 28427998
[TBL] [Abstract][Full Text] [Related]
17. The size of the proteasomal substrate determines whether its degradation will be mediated by mono- or polyubiquitylation.
Shabek N; Herman-Bachinsky Y; Buchsbaum S; Lewinson O; Haj-Yahya M; Hejjaoui M; Lashuel HA; Sommer T; Brik A; Ciechanover A
Mol Cell; 2012 Oct; 48(1):87-97. PubMed ID: 22902562
[TBL] [Abstract][Full Text] [Related]
18. Ubiquitination of the transcription factor c-MAF is mediated by multiple lysine residues.
Chen G; Xu X; Tong J; Han K; Zhang Z; Tang J; Li S; Yang C; Li J; Cao B; Zhou H; Wu D; Moran MF; Mao X
Int J Biochem Cell Biol; 2014 Dec; 57():157-66. PubMed ID: 25448412
[TBL] [Abstract][Full Text] [Related]
19. Quantitative analysis of in vitro ubiquitinated cyclin B1 reveals complex chain topology.
Kirkpatrick DS; Hathaway NA; Hanna J; Elsasser S; Rush J; Finley D; King RW; Gygi SP
Nat Cell Biol; 2006 Jul; 8(7):700-10. PubMed ID: 16799550
[TBL] [Abstract][Full Text] [Related]
20. Approaches to Determine Protein Ubiquitination Residue Types.
Chen Q; Yang X; Xie Q
Methods Mol Biol; 2016; 1450():3-10. PubMed ID: 27424741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
